Transcription of Network Contract Directed Enhanced Service
{{id}} {{{paragraph}}}
Classification: Official Network Contract Directed Enhanced Service Structured medication reviews and medicines optimisation : guidance 31 March 2021. Network Contract Directed Enhanced Service Structured medication reviews and medicines optimisation : guidance Publishing approval number: PAR431. Version number: 1. First published: 31 March 2021. Prepared by: Primary Care Group This information can be made available in alternative formats, such as large print, and may be available in alternative languages, upon request. Please contact the Primary Care Group at Classification: Official Contents 1. 2. 2. Introduction .. 2. Existing provision and available support for PCNs .. 3. 3. Guidance to support implementation of the 2020/21 Service requirements.
1 Problematic polypharmacy arises when multiple medicines are prescribed inappropriately, or when the intended benefit of the medicines is not realised or appropriately monitored, potentially due to clinical complexity or clinical capacity. 2 NICE guideline 5: Medicines optimisation: the safe and effective use of medicines to enable the
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}